tizanidine

Generic: tizanidine

Labeler: a-s medication solutions
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name tizanidine
Generic Name tizanidine
Labeler a-s medication solutions
Dosage Form TABLET
Routes
ORAL
Active Ingredients

tizanidine hydrochloride 4 mg/1

Manufacturer
A-S Medication Solutions

Identifiers & Regulatory

Product NDC 50090-6756
Product ID 50090-6756_4ccf302b-0c01-4e14-81a5-2904b7116e78
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA076286
Listing Expiration 2026-12-31
Marketing Start 2021-06-15

Pharmacologic Class

Classes
adrenergic alpha2-agonists [moa] central alpha-2 adrenergic agonist [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 500906756
Hyphenated Format 50090-6756

Supplemental Identifiers

RxCUI
313413
UNII
B53E3NMY5C

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name tizanidine (source: ndc)
Generic Name tizanidine (source: ndc)
Application Number ANDA076286 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 4 mg/1
source: ndc
Packaging
  • 120 TABLET in 1 BOTTLE (50090-6756-0)
  • 60 TABLET in 1 BOTTLE (50090-6756-2)
  • 15 TABLET in 1 BOTTLE (50090-6756-3)
  • 30 TABLET in 1 BOTTLE (50090-6756-4)
  • 90 TABLET in 1 BOTTLE (50090-6756-6)
  • 14 TABLET in 1 BOTTLE (50090-6756-7)
source: ndc

Packages (6)

50090-6756-0 120 TABLET in 1 BOTTLE (50090-6756-0) 50090-6756-2 60 TABLET in 1 BOTTLE (50090-6756-2) 50090-6756-3 15 TABLET in 1 BOTTLE (50090-6756-3) 50090-6756-4 30 TABLET in 1 BOTTLE (50090-6756-4) 50090-6756-6 90 TABLET in 1 BOTTLE (50090-6756-6) 50090-6756-7 14 TABLET in 1 BOTTLE (50090-6756-7)

Ingredients (1)

tizanidine hydrochloride (4 mg/1)

Linked Drug Pages (1)

Tizanidine ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "4ccf302b-0c01-4e14-81a5-2904b7116e78", "openfda": {"unii": ["B53E3NMY5C"], "rxcui": ["313413"], "spl_set_id": ["67b2af93-92c9-4c33-8fa0-548bfcc9c538"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "120 TABLET in 1 BOTTLE (50090-6756-0)", "package_ndc": "50090-6756-0", "marketing_start_date": "20231017"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (50090-6756-2)", "package_ndc": "50090-6756-2", "marketing_start_date": "20231017"}, {"sample": false, "description": "15 TABLET in 1 BOTTLE (50090-6756-3)", "package_ndc": "50090-6756-3", "marketing_start_date": "20231017"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (50090-6756-4)", "package_ndc": "50090-6756-4", "marketing_start_date": "20231017"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (50090-6756-6)", "package_ndc": "50090-6756-6", "marketing_start_date": "20231017"}, {"sample": false, "description": "14 TABLET in 1 BOTTLE (50090-6756-7)", "package_ndc": "50090-6756-7", "marketing_start_date": "20231017"}], "brand_name": "Tizanidine", "product_id": "50090-6756_4ccf302b-0c01-4e14-81a5-2904b7116e78", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha2-Agonists [MoA]", "Central alpha-2 Adrenergic Agonist [EPC]"], "product_ndc": "50090-6756", "generic_name": "Tizanidine", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tizanidine", "active_ingredients": [{"name": "TIZANIDINE HYDROCHLORIDE", "strength": "4 mg/1"}], "application_number": "ANDA076286", "marketing_category": "ANDA", "marketing_start_date": "20210615", "listing_expiration_date": "20261231"}